Iovance Biotherapeutics, Inc. (IOVA) stock analysis

In our weekly check, Iovance Biotherapeutics, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 3, red flags: 9.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as IOVA.

What our checks show for IOVA

Red flags

Warning signs

Strengths

Similar companies

ELVN · ARQT · VRDN · VKTX · ABCL

Questions

What grade does Iovance Biotherapeutics, Inc. (IOVA) have?

In our weekly check, Iovance Biotherapeutics, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 3, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of IOVA stock?

This week's biggest flags for Iovance Biotherapeutics, Inc.: Margins falling, Weak EPS growth, Thin margins. In total 12 of 20 checks show a warning or a red flag.

What does Iovance Biotherapeutics, Inc. do?

Iovance Biotherapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as IOVA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis